Mitumomab

Revision as of 20:21, 27 September 2011 by WikiBot (talk | contribs) (Protected "Mitumomab": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Template:Drugbox-mab

WikiDoc Resources for Mitumomab

Articles

Most recent articles on Mitumomab

Most cited articles on Mitumomab

Review articles on Mitumomab

Articles on Mitumomab in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Mitumomab

Images of Mitumomab

Photos of Mitumomab

Podcasts & MP3s on Mitumomab

Videos on Mitumomab

Evidence Based Medicine

Cochrane Collaboration on Mitumomab

Bandolier on Mitumomab

TRIP on Mitumomab

Clinical Trials

Ongoing Trials on Mitumomab at Clinical Trials.gov

Trial results on Mitumomab

Clinical Trials on Mitumomab at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Mitumomab

NICE Guidance on Mitumomab

NHS PRODIGY Guidance

FDA on Mitumomab

CDC on Mitumomab

Books

Books on Mitumomab

News

Mitumomab in the news

Be alerted to news on Mitumomab

News trends on Mitumomab

Commentary

Blogs on Mitumomab

Definitions

Definitions of Mitumomab

Patient Resources / Community

Patient resources on Mitumomab

Discussion groups on Mitumomab

Patient Handouts on Mitumomab

Directions to Hospitals Treating Mitumomab

Risk calculators and risk factors for Mitumomab

Healthcare Provider Resources

Symptoms of Mitumomab

Causes & Risk Factors for Mitumomab

Diagnostic studies for Mitumomab

Treatment of Mitumomab

Continuing Medical Education (CME)

CME Programs on Mitumomab

International

Mitumomab en Espanol

Mitumomab en Francais

Business

Mitumomab in the Marketplace

Patents on Mitumomab

Experimental / Informatics

List of terms related to Mitumomab

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Mitumomab is a mouse, anti-Idiotypic monoclonal antibody that targets GD3 ganglioside, which is over-expressed predominantly on tumours origination from the neuroectoderm.


Template:Mousemonoclonals Template:SIB Template:WH Template:WikiDoc Sources